A phase 2 study of MK-0457 in patients with BCR-ABL T315I mutant chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia

J. F. Seymour, D. W. Kim, E. Rubin, A. Haregewoin, J. Clark, P. Watson, T. Hughes, I. Dufva, J. L. Jimenez, F. X. Mahon, P. Rousselot, J. Cortes, G. Martinelli, C. Papayannidis, A. Nagler, F. J. Giles

Research output: Contribution to journalArticlepeer-review

49 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 2 study of MK-0457 in patients with BCR-ABL T315I mutant chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences